GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 122 filers reported holding GOSSAMER BIO INC in Q4 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $180,076 | -78.3% | 150,063 | -77.3% | 0.00% | -66.7% |
| Q1 2023 | $831,505 | -58.1% | 659,925 | -27.9% | 0.00% | -62.5% |
| Q4 2022 | $1,985,389 | -31.1% | 914,926 | +280.4% | 0.01% | -46.7% |
| Q3 2022 | $2,882,000 | +955.7% | 240,546 | +638.8% | 0.02% | +650.0% |
| Q2 2022 | $273,000 | -38.0% | 32,561 | -35.8% | 0.00% | 0.0% |
| Q1 2022 | $440,000 | +411.6% | 50,747 | +379.9% | 0.00% | – |
| Q2 2021 | $86,000 | -69.2% | 10,575 | -65.0% | 0.00% | -100.0% |
| Q1 2021 | $279,000 | -46.7% | 30,188 | -44.2% | 0.00% | -50.0% |
| Q4 2020 | $523,000 | +195.5% | 54,117 | +278.8% | 0.00% | +100.0% |
| Q3 2020 | $177,000 | -2.2% | 14,286 | +2.8% | 0.00% | -33.3% |
| Q2 2020 | $181,000 | -2.7% | 13,893 | -24.2% | 0.00% | -40.0% |
| Q1 2020 | $186,000 | -64.4% | 18,323 | -45.2% | 0.01% | +66.7% |
| Q4 2019 | $523,000 | – | 33,437 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 8,055,916 | $6,708,967 | 4.36% |
| Velan Capital Investment Management LP | 3,065,136 | $2,552,645 | 2.06% |
| Monashee Investment Management LLC | 5,304,212 | $4,417,348 | 1.84% |
| CVI Holdings, LLC | 976,108 | $812,903 | 1.61% |
| Samsara BioCapital, LLC | 6,130,268 | $5,105,287 | 1.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 6,130,268 | $5,105,287 | 1.55% |
| Opaleye Management Inc. | 4,754,200 | $3,959,298 | 1.29% |
| Octagon Capital Advisors LP | 8,187,883 | $6,818,869 | 1.05% |
| NEA Management Company, LLC | 15,727,942 | $13,098,230 | 1.01% |
| GREAT POINT PARTNERS LLC | 6,230,272 | $5,188,571 | 0.94% |